Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Shows the quality of life of patients with aspects of fatigue, emotional function, worries, abdominal symptoms, activity and systemic symptoms assessed by CQLD. Patients with ACLF showed a significantly reduced quality of life in terms of worry (4,48 ± 1,3 vs. 3,57 ± 1,2) and systemic symptoms (4,48 ± 1,6 vs. 3,29 ± 1,2)

From: Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relatives

ParameterDecompensated liver cirrhosis
(N = 42)
Acute-on-chronic liver failure
(N = 21)
P Value
Fatigue (MEAN; SD)3,98 ± 1,123,76 ± 1,090,5
Emotional Function (MEAN; SD)4,24 ± 1,143,67 ± 1,070,06
Worries (MEAN; SD)4,48 ± 1,273,57 ± 1,170,008
Abdominal symptoms (MEAN; SD)4,43 ± 1,43,9 ± 1,220,2
Activity (MEAN; SD)4,43 ± 1,314,1 ± 1,550,4
Systemic symptoms (MEAN; SD)4,48 ± 1,583,29 ± 1,190,004
Total Quality of Life (MEAN; SD)4,33 ± 1,143,67 ± 0,910,02